IRIS
COSTANTINO, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.013
AS - Asia 5.052
EU - Europa 4.020
SA - Sud America 869
AF - Africa 270
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 17.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.845
SG - Singapore 2.081
CN - Cina 1.638
IT - Italia 715
BR - Brasile 693
IE - Irlanda 639
SE - Svezia 630
DE - Germania 479
FI - Finlandia 446
HK - Hong Kong 438
UA - Ucraina 394
VN - Vietnam 303
TR - Turchia 222
NL - Olanda 212
ZA - Sudafrica 164
CA - Canada 107
RU - Federazione Russa 104
GB - Regno Unito 85
IN - India 82
AR - Argentina 62
AT - Austria 56
FR - Francia 48
CI - Costa d'Avorio 41
EC - Ecuador 40
MX - Messico 39
PL - Polonia 39
BD - Bangladesh 38
IQ - Iraq 38
BE - Belgio 33
ID - Indonesia 31
CZ - Repubblica Ceca 30
JP - Giappone 28
ES - Italia 25
PK - Pakistan 21
KR - Corea 19
CO - Colombia 17
PY - Paraguay 17
UZ - Uzbekistan 15
LT - Lituania 14
EG - Egitto 13
IR - Iran 13
LU - Lussemburgo 13
RO - Romania 12
VE - Venezuela 11
IL - Israele 10
RS - Serbia 9
PA - Panama 8
PE - Perù 8
SA - Arabia Saudita 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DZ - Algeria 7
KG - Kirghizistan 7
MA - Marocco 7
TN - Tunisia 7
EU - Europa 6
KZ - Kazakistan 6
SN - Senegal 6
BG - Bulgaria 5
CL - Cile 5
KE - Kenya 5
NP - Nepal 5
AZ - Azerbaigian 4
HR - Croazia 4
JO - Giordania 4
KW - Kuwait 4
MY - Malesia 4
NZ - Nuova Zelanda 4
RW - Ruanda 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AU - Australia 3
CH - Svizzera 3
CM - Camerun 3
EE - Estonia 3
JM - Giamaica 3
LB - Libano 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
SD - Sudan 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GR - Grecia 2
HN - Honduras 2
LV - Lettonia 2
NO - Norvegia 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
CG - Congo 1
Totale 17.224
Salva come PNG Salva come JPEG
Città #
Dallas 1.705
Singapore 1.091
Ashburn 677
Chandler 644
Dublin 636
Jacksonville 490
Beijing 460
Hong Kong 436
Santa Clara 349
Parma 333
Ann Arbor 225
Boardman 196
Nanjing 188
Izmir 170
Princeton 154
Johannesburg 151
Dearborn 146
Munich 111
Wilmington 110
Ho Chi Minh City 107
Los Angeles 102
Shanghai 102
San Mateo 100
Helsinki 92
Hefei 87
New York 77
Hanoi 71
Nanchang 67
Toronto 67
Bremen 65
Columbus 58
Moscow 56
São Paulo 56
Shenyang 53
Hebei 44
Jinan 43
Abidjan 41
Jiaxing 41
Turku 41
Buffalo 40
Kunming 40
Chicago 39
Guangzhou 38
Vienna 37
Houston 36
The Dalles 36
Warsaw 36
Des Moines 34
Brooklyn 33
Milan 32
Tianjin 31
Changsha 29
Brussels 25
Norwalk 25
Jakarta 24
Kocaeli 24
Tokyo 24
Atlanta 23
Council Bluffs 23
Frankfurt am Main 23
Bologna 22
Seattle 22
London 21
San Jose 21
Falls Church 20
Orem 20
Chennai 19
Boston 18
Haiphong 18
Rio de Janeiro 18
Belo Horizonte 17
Curitiba 17
Quito 17
Baghdad 16
Brno 16
Istanbul 16
Nuremberg 16
Seoul 16
Zhengzhou 16
Denver 15
San Francisco 15
Stockholm 14
Woodbridge 14
Bengaluru 13
Modena 13
Amsterdam 12
Da Nang 12
Montreal 12
Poplar 12
Tashkent 12
Biên Hòa 11
Dhaka 11
Hangzhou 11
Borås 10
Brasília 10
Haikou 10
Manchester 10
Fremont 9
Luxembourg 9
Phoenix 9
Totale 10.884
Salva come PNG Salva come JPEG
Nome #
1,4-Benzothiazine and 1,4-benzoxazine imidazole derivatives with antifungal activity: a docking study 1.568
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 229
The in silico drug discovery toolbox: applications in lead discovery and optimization 217
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 192
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 183
Nuovi composti antimicrobici 177
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 171
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 159
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 158
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 157
Design and synthesis of trans-2-substituted-cyclopropane-1-carboxylic acids as the first non-natural small molecule inhibitors of O-acetylserine sulfhydrylase 157
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 157
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 156
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 152
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 150
Probing the Reactivity of 2,4-Dichlorofuro[3,4-d ]pyrimidin-7-one: A Versatile and Underexploited Scaffold to Generate Substituted or Fused Pyrimidine Derivatives 148
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 145
Scaffold Morphing Approach To Expand the Toolbox of Broad-Spectrum Antivirals Blocking Dengue/Zika Replication 139
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 138
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 137
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 136
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 133
1-Aminoindane-1,5-dicarboxylic Acid: a Novel Antagonist at Phospholipase C Linked Metabotropic Glutamate Receptors 132
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 132
Metabolite Profiling and Bioactivities of Leaves, Stems, and Flowers of Rumex usambarensis (Dammer) Dammer, a Traditional African Medicinal Plant 130
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 129
Extraction and Quantification of Azelaic Acid from Different Wheat Samples (Triticum durum Desf.) and Evaluation of Their Antimicrobial and Antioxidant Activities 126
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 126
Aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step towards new anti-excitotoxic agents 125
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 125
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 124
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 122
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 122
QSAR and Molecular Modeling Studies of Baclofen Analogs as GABAB Agonists. Insights into the Role of the Aromatic Moiety in GABAB Binding and Activation. 121
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 121
Inhibition of O-acetylserine sulfhydrylase by fluoroalanine derivatives 120
Antibacterial and antibiofilm activity of Eucalyptus globulus leaf extract, asiatic acid and ursolic acid against bacteria isolated from bovine mastitis 119
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 119
Molecular dynamics simulations and docking studies on 3D models of the heterodimeric and homodimeric 5-HT(2A) receptor subtype. 118
Dirhodium(II)-tetraacetate-Mediated Decomposition of Ethyldiazo- acetate and Ethyldiazomalonate in the Presence of Fullerene. A New Procedure for the Selective Synthesis of [6-6]-Closed Methanofullerenes 118
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 117
A multicomponent pharmacophore fragment-decoration approach to identify selective LRRK2-targeting probes 116
A High Performance Workflow for Chemistry Driven de Novo Design 115
A one-pot two-step microwave-assisted synthesis of N1-substituted 5,6-ring-fused 2-pyridones 115
alfa-Diazocarbonyl Chemistry - Target Driven Applications 115
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 114
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 113
ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY OF EUCALYPTUS GLOBULUS LEAVES EXTRACT AND ITS MAIN COMPOUNDS ON MASTITIS PATHOGENS OF DAIRY COWS. 112
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 110
A microwave-assisted multicomponent protocol for the synthesis of benzofuran-2-carboxamides 108
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 108
Identification of Breast Cancer Inhibitors Specific for G Protein-Coupled Estrogen Receptor (GPER)-Expressing Cells 108
Chemical Markers in Italian Propolis: Chrysin, Galangin and CAPE as Indicators of Geographic Origin 108
6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 106
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 106
Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn Kinases 106
Use of Experimental Design To Optimize Docking Performance: The Case of LiGenDock, the Docking Module of Ligen, a New De Novo Design Program 105
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 105
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 105
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 105
In silico approaches towards the understanding of the structure-function relationships in metabotropic glutamate receptors (mGluRs) and other family C GPRCs. 104
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 103
Autocorrelation as a tool for a congruent description of molecules in 3D-QSAR studies 101
Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds 101
Nuova composizione 101
Asymmetric Synthesis of Enantiomerically Pure (2S,1'S,2'S,3'R)-phenylcarboxycyclopropylglycine (PCCG-4): A Potent and Selective Ligand at Group II Metabotropic Glutamate Receptors 100
Computational Insights into the mechanism of inhibition of OASS-A by a small molecule inhibitor 99
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 97
S-(+)-2-(3'-Carboxy-bicyclo[1.1.1]pentyl)glycine, a Structurally New Group I Metabotropic Glutamate Receptor Antagonist 96
Derivatives of Nicotinic Acid N-Oxide, their preparation and their use as inhibitors of enzyme 3-hydroxyanthranilate-3,4-dioxygenase 95
Synthesis and Biological Evaluation of 6-Carboxy-3,4-methanoprolines, New Rigid Glutamate Analogs 94
Predictive binding of .beta.-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach 94
Design, Synthesis and Preliminary Evaluation of Novel 3’-Substituted Carboxycyclopropylglycines as Antagonists at Group 2 Metabotropic Glutamate Receptors 94
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 94
Synthesis and biological evaluation of (2S)- and (2R)-2-(3'-phosphonobicyclo[1.1.1]pentyl)glycines as novel group III selective metabotropic glutamate receptor ligands. 93
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 93
Antimicrobial peptides (AMPs): a patent review (2015-2020) 92
Synthesis of 6,6-Dicarboxy-3,4-methano-L-proline, a New Constrained Glutamate Analog Endowed with Neuroprotective Properties 92
Generating optimal linear PLS estimation (GOLPE). An advanced chemometric tool for handling 3D-QSAR problems 91
Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP). 90
Life or death decisions: the cast of poly(ADP-ribose)polymerase (PARP) as a therapeutic target for brain ischaemia. 89
Back door modulation of the farnesoid X receptor: design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives. 89
Membrane-Sensitive Conformational States of Helix 8 in the Metabotropic Glu2 Receptor, a Class C GPCR 88
(2R,1'S,2'R,3'S)-2-(2'-Carboxy-3'-phenylcyclopropyl)glycine (PCCG-13), the first potent and selective competitive antagonist of phospholipase D-coupled metabotropic glutamate receptors: asymmetric synthesis and preliminary biological properties 88
Addressing the Conformational Flexibility of Serine Racemase by Combining Targeted Molecular Dynamics, Conformational Sampling and Docking Studies 88
Heterocyclic modulators of the NMDA Receptor 88
Homology model of the closed, functionally active, form of the amino terminal domain of mGlur1. 87
Series Design 86
Homology Modeling, Validation and Dynamics of the G Protein-coupled Estrogen Receptor 1 (GPER-1) 85
Homology Modeling of Metabotropic Glutamate Receptors (mGluRs). Structural Motifs Affecting Binding Modes and Pharmacological Profile of mGluR1 Agonists and Competitive Antagonists 83
Sodium channel blockers for neuropathic pain. 82
Predictive ability of regression models. Part II: Selection of the best predictive PLS model 82
Kynurenine-3-hydroxylase and its Selective Inhibitors: Molecular Modelling Studies 81
Predictive ability of regression models. Part I: Standard Deviation of Prediction Errors (SDEP) 81
Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. 80
Binding modes of noncompetitive AMPA antagonists: a computational approach 79
Molecular dynamics simulation of the heterodimeric mGluR2/5HT(2A) complex. An atomistic resolution study of a potential new target in psychiatric conditions. 79
Modulation of glutamate receptor pathways in the search for new neuroprotective agents. 78
Bulky 1,4-benzoxazine derivatives with antifungal activity. 78
Disjoint Principal Properties of Organic Substituents 78
Totale 12.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021596 0 0 0 0 0 24 97 50 219 48 137 21
2021/2022796 19 35 20 41 28 37 88 111 47 50 67 253
2022/20232.630 338 289 143 177 248 309 34 161 791 20 79 41
2023/2024940 59 79 27 48 96 148 87 68 31 57 100 140
2024/20253.477 96 203 278 169 315 343 145 149 374 315 370 720
2025/20265.755 739 1.043 1.900 716 1.046 311 0 0 0 0 0 0
Totale 17.388